| Top 50 Most Viewed Posts Last Month |
|---|
|
Today This Week Last Week This Month Last Month
|
1. My69z: 3 yrs ago -- ICI Agreement with major institution (3190)  (8) |
| 2. KenChowder: $30M at a share price of $.25 would buy120M (2624) (19) |
| 3. KenChowder: Here's my favorite part of the new interview from (2573) (22) |
| 4. sherlock57: Merck? Really??? Even though they are in three (2403) (15) |
| 5. KenChowder: Misiu asked me to post the one-year numbers for (2358) (15) |
| 6. Rosner: Short Interest Report As of Sat, Aug 3, '13 (2138) |
| 7. Ganesha: Re: Current EIND policy at CYDY I wanted to let (2092) (40) |
| 8. MGK_2: Patient A, is a 78-year-old female with a (2064) (15) |
| 9. KenChowder: Of course we might always get good news before (1998) (13) |
| 10. Katangolo: Fair point, but let’s keep perspective. Whether (1852) (26) |
| 11. RTB: The idea that buyer and seller are projecting a (1735) (18) |
| 12. sherlock57: I read somewhere--probably one of the PRs--that (1702) (20) |
| 13. USS JOHNSTON: Merck pays 9 billion dollars for a drug that can (1275) (13) |
| 14. KenChowder: Misiu's pessimistic appraisal was based on an (1088) (18) |
| 15. twinter11: CCR5-related signalling may link peripheral (1023) (6) |
| 16. cardamine: I'm not exactly in the know, but I thought that (992) |
| 17. Hanman: A question for those in the know. Is there a (991) (5) |
| 18. HHIGambler: As a mod, we have to look at it from a different (962) (16) |
| 19. misiu143: https://www.debrecensun.hu/uni/2025/11/17/renowne (934) (17) |
| 20. brentie: These mouse trial results certainly sound (924) (27) |
| 21. mightycydy: New Interview - Robert Hoffman - CFO CytoDyn (911) (22) |
| 22. sean007: Merck gets EU nod... for subcutaneous version of (906) (5) |
| 23. DJknows: Been in that one since 2022... when I get into a (896) (7) |
| 24. KenChowder: My wrote: from Dr. Jay interview, Min. 21:30 "And (891) (15) |
| 25. sherlock57: Nice find, mfglola. In addition to vilastobart, (890) (26) |
| 26. Camp2800: Maybe we are next! Johnson & Johnson (JNJ) has (882) (5) |
| 27. Evil Rabbit: Maybe I’m an eternal optimist, but I can’t (876) (34) |
| 28. Evil Rabbit: Great listen: Turning Cold Tumors Hot to (869) (27) |
| 29. Jake13: $CBT Cabot Corp 55.72 Had 59,859 1 Month Highs. (862) |
| 30. misiu143: Very interesting information , thank you !! (862) |
| 31. Cassandra X: One small correction of Ken's transcript of the (859) (28) |
| 32. sean007: Speaking of Scott Gottlieb, M.D. Former head of (856) (4) |
| 33. Evil Rabbit: Take note, Dr. Sacha, see how easy it is to (855) (17) |
| 34. Boatbuilder: Couldn’t help myself…. :) And yes I still (853) (4) |
| 35. twinter11: Let's get down w/ the science This was posted to (841) (8) |
| 36. My69z: Mr. Hoffman says, going to look @ CRC PD-L1 (841) (6) |
| 37. My69z: From the S3 -- *Unless otherwise set forth in a (840) (6) |
| 38. brentie: https://www.geneonline.com/regulatory-t-cells-lin (838) (10) |
| 39. SporadicE: This is a very good thing. Really hope CYDY (826) (4) |
| 40. KenChowder: This is pretty amazing stuff from Pestell, Burger (824) (24) |
| 41. mountaineer: Yorkville advisors has a significant financial (819) (9) |
| 42. Enjay: Dr. Pestell was co-author of a report entitled (809) (10) |
| 43. chazzledazzle: From Cytosphere on Reddit. San Antonio Breast (803) (16) |
| 44. BuckCYDYLong: Gonna beat the dead horse again on the Nobel (803) (5) |
| 45. docj: Bunch of Hungarians and Pestell got drunk and (791) (3) |
| 46. hoops: Does this help? Choice of New FDA Drug Chief (776) (7) |
| 47. My69z: 1-2 months / not 30 - 90 days that we have only (773) (8) |
| 48. Hanman: Thanks for the reply Cardamine. Yes, that's (773) (1) |
| 49. Katangolo: Man, you’ve been through this. Long enough to (771) (14) |
| 50. misiu143: Dr Pestell , mTNBC and leronlimab.. (771) (24) |
